Shares of micro-cap Achieve Life Sciences rose 5% on Tuesday, January 7, following the company’s announcement that its clinical trial for a smoking cessation drug successfully reached a critical milestone. This progress allows Achieve to file for regulatory approval and, if granted, begin commercial sales. Details On January 7, Achieve’s…